Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification and characterization of phytocannabinoids as novel dual PPARα/γ agonists by a computational and in vitro experimental approach
Enrico D’Aniello, Tariq G. Fellous, Fabio Arturo Iannotti, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2019) Vol. 1863, Iss. 3, pp. 586-597
Closed Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

The Pharmacological Case for Cannabigerol
Rahul Nachnani, Wesley M. Raup‐Konsavage, Kent E. Vrana
Journal of Pharmacology and Experimental Therapeutics (2020) Vol. 376, Iss. 2, pp. 204-212
Open Access | Times Cited: 150
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 91
Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
Kenneth B. Walsh, Amanda E. McKinney, Andrea E. Holmes
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 99
The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation
Fabio Arturo Iannotti, Rosa Maria Vitale
Cells (2021) Vol. 10, Iss. 3, pp. 586-586
Open Access | Times Cited: 84
Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors
Gemma Navarro, Katia Varani, Alejandro Lillo, et al.
Pharmacological Research (2020) Vol. 159, pp. 104940-104940
Open Access | Times Cited: 78
Phenolic-protein interactions in foods and post ingestion: Switches empowering health outcomes
Hui Guan, Wenyuan Zhang, Dongxiao Sun‐Waterhouse, et al.
Trends in Food Science & Technology (2021) Vol. 118, pp. 71-86
Closed Access | Times Cited: 59
A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid
Hebaallah Mamdouh Hashiesh, Charu Sharma, Sameer N. Goyal, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 140, pp. 111639-111639
Open Access | Times Cited: 57
The Origin and Biomedical Relevance of Cannabigerol
Anna Jastrząb, Iwona Jarocka-Karpowicz, Elżbieta Skrzydlewska
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7929-7929
Open Access | Times Cited: 57
Cannabidiol goes nuclear: The role of PPARγ
Sara Khosropoor, Mohaddeseh Sadat Alavi, Leila Etemad, et al.
Phytomedicine (2023) Vol. 114, pp. 154771-154771
Closed Access | Times Cited: 30
The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders
Vincenzo Di Marzo
Dialogues in Clinical Neuroscience (2020) Vol. 22, Iss. 3, pp. 259-269
Open Access | Times Cited: 62
Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications
Hebaallah Mamdouh Hashiesh, Mohamed Fizur Nagoor Meeran, Charu Sharma, et al.
Nutrients (2020) Vol. 12, Iss. 10, pp. 2963-2963
Open Access | Times Cited: 56
Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?
Leontina Elena Filipiuc, Daniela Carmen Ababei, Teodora Alexa‐Stratulat, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1823-1823
Open Access | Times Cited: 56
Beneficial Effects of Akkermansia muciniphila Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists
Clara Depommier, Rosa Maria Vitale, Fabio Arturo Iannotti, et al.
Cells (2021) Vol. 10, Iss. 1, pp. 185-185
Open Access | Times Cited: 53
Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles
Ronit Vogt Sionov, Doron Steinberg
Biomedicines (2022) Vol. 10, Iss. 3, pp. 631-631
Open Access | Times Cited: 29
Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids
Rafael Franco, Rafael Rivas‐Santisteban, Irene Reyes‐Resina, et al.
Pharmacological Research (2020) Vol. 158, pp. 104801-104801
Closed Access | Times Cited: 40
Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System
Ana Lago-Fernandez, Sara Zarzo-Arias, Nadine Jagerovic, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1001-1001
Open Access | Times Cited: 39
Cannabigerol: a bibliometric overview and review of research on an important phytocannabinoid
Chinedu P. Anokwuru, Felix L. Makolo, Maxleene Sandasi, et al.
Phytochemistry Reviews (2022) Vol. 21, Iss. 5, pp. 1523-1547
Closed Access | Times Cited: 24
Black rice (Oryza sativa L.) reduces obesity and improves lipid metabolism in C57BL/6J mice fed a high-fat diet
Dong Liu, Yanglin Ji, Jiang Zhao, et al.
Journal of Functional Foods (2019) Vol. 64, pp. 103605-103605
Open Access | Times Cited: 43
Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent
Shahar Azar, Shiran Udi, Adi Drori, et al.
Molecular Metabolism (2020) Vol. 42, pp. 101087-101087
Open Access | Times Cited: 37
Phytochemical Profiling and Biological Evaluation of the Residues from Industrial Hemp (Cannabis sativa L.) Inflorescences Trimming: Focus on Water Extract
Simonetta Cristina Di Simone, Maria Loreta Libero, Riccardo Pulcini, et al.
Food Bioscience (2024), pp. 105344-105344
Open Access | Times Cited: 4
β-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDG
Maria Monticelli, Ludovica Liguori, Mariateresa Allocca, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4164-4164
Open Access | Times Cited: 35
N-palmitoyl-D-glucosamine, A Natural Monosaccharide-Based Glycolipid, Inhibits TLR4 and Prevents LPS-Induced Inflammation and Neuropathic Pain in Mice
Monica Iannotta, Carmela Belardo, Maria Consiglia Trotta, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1491-1491
Open Access | Times Cited: 27
Topical Use of Cannabis sativa L. Biochemicals
Léonid Mnekin, Lionel Ripoll
Cosmetics (2021) Vol. 8, Iss. 3, pp. 85-85
Open Access | Times Cited: 26
Minor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research
Diego Caprioglio, Hawraz Ibrahim M. Amin, Orazio Taglialatela‐Scafati, et al.
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1084-1084
Open Access | Times Cited: 19
Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes
Camilla Di Meo, Daniel Tortolani, Sara Standoli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5430-5430
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top